News
The alliance brings both companies' offerings under a single operating platform.
The company will use the funding to further develop its SmartShunt System, aimed at reducing shunt failures and improving care for patients with hydrocephalus.
Also, Singapore has approved a lung cancer imaging AI platform.
Smile Digital Health will integrate MCG Path, a FHIR-based application programming interface offering, with Smile's CMS Suite.
The alliance will center on the discovery, development and commercialization of radioligand therapies for imaging and treatment of solid tumors.
The aim of Agent Studio is to free up teams, accelerate trials, reduce costs and bring medicines to patients faster.
The platform helps healthcare teams with the burden of non-actionable alarms and cognitive overload.
The five-year strategy aims to simplify and personalize healthcare for patients and clinical teams.
Developed at Hallym University, the device integrates visual, eye movement, and vertigo tests in one.
The DECODE Obesity working group aims to evaluate physical activity, function and sleep in a remote patient environment.